Capstone Investment Advisors, LLC Pfizer Inc Call Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $168,970 - $191,479	-6,100 Reduced 1.18%	510,500 $14.8 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $7.21 Million - $8.45 Million	285,600 Added 123.64%	516,600 $14.5 Million
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $14.6 Million - $16.8 Million	-563,800 Reduced 70.94%	231,000 $6.41 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $11.3 Million - $14.7 Million	433,200 Added 119.8%	794,800 $22.9 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $173,286 - $202,554	5,400 Added 1.52%	361,600 $12 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $2.82 Million - $3.26 Million	78,000 Added 28.04%	356,200 $13.1 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $2.33 Million - $3.04 Million	59,200 Added 27.03%	278,200 $11.4 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $1.21 Million - $1.59 Million	29,100 Added 15.32%	219,000 $11.2 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $988,976 - $1.21 Million	-22,600 Reduced 10.64%	189,900 $8.31 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $18.6 Million - $22.1 Million	-400,000 Reduced 65.31%	212,500 $11.1 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $36.3 Million - $45 Million	-793,900 Reduced 56.45%	612,500 $31.7 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $7.49 Million - $11.1 Million	-181,200 Reduced 11.41%	1,406,400 $83 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $1.99 Million - $2.56 Million	50,800 Added 3.31%	1,587,600 $68.3 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $639,197 - $724,104	17,800 Added 1.17%	1,536,800 $60.2 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $1.45 Million - $1.64 Million	-43,400 Reduced 2.78%	1,519,000 $55 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $18.5 Million - $23.6 Million	553,900 Added 54.92%	1,562,400 $57.5 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $16.5 Million - $19.3 Million	518,800 Added 105.94%	1,008,500 $37 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $2.18 Million - $2.65 Million	72,400 Added 17.35%	489,700 $16 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $18.9 Million - $27 Million	-698,600 Reduced 62.6%	417,300 $13.6 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $8.6 Million - $9.76 Million	261,300 Added 30.58%	1,115,900 $43.7 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $16.3 Million - $21.2 Million	502,900 Added 142.99%	854,600 $30.7 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $5.84 Million - $6.56 Million	157,900 Added 81.48%	351,700 $15.2 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $442,500 - $486,160	-11,800 Reduced 5.74%	193,800 $8.23 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $2.29 Million - $2.61 Million	59,500 Added 40.73%	205,600 $8.97 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $4.85 Million - $5.88 Million	140,700 Added 2605.56%	146,100 $6.44 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $178,091 - $189,863	5,400 New	5,400 $196,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.8 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.77 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.38 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.48 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account